ProMIS Neurosciences announced a strategic leadership change. The Company’s Board of Directors appointed Neil Warma as interim Chief Executive Officer to succeed Gail Farfel, Ph.D., who has stepped down to pursue other opportunities. Warma has served as an independent Director on ProMIS’ Board since 2022.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on PMN:
- ProMIS Neurosciences, Inc. Announces Leadership Transition
- ProMIS Neurosciences announces publication on novel target for ALS
- ProMIS Neurosciences Announces Publication on Novel Target for ALS
- ProMIS Neurosciences doses first subjects in Phase 1a trial of PMN310
Questions or Comments about the article? Write to editor@tipranks.com